Metraipolis › archive › dc_926817c8f33b

Case Report: Navigating novel therapies and systemic barriers in ovarian clear cell carcinoma through a complete response to lenvatinib, pembrolizumab, and SFRT — Europe PMC PMID:41487560

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41487560
DOI: 10.3389/fonc.2025.1679554
License (as archived): solo-consultazione
Archived: 2026-10-06T10:22:50.015Z
SHA-256 of the archived text: 161f47932d88836a19b730b7bbcf35731b9ed1efaba93b57179c4cfa40372ecb
Stable URL of this page: https://metraipolis.com/documento/dc_926817c8f33b

How to cite

Case Report: Navigating novel therapies and systemic barriers in ovarian clear cell carcinoma through a complete response to lenvatinib, pembrolizumab, and SFRT — Europe PMC PMID:41487560 — Europe PMC (en), https://europepmc.org/article/MED/41487560 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_926817c8f33b (Metraipolis archive dc_926817c8f33b, sha256 161f47932d88836a19b730b7bbcf35731b9ed1efaba93b57179c4cfa40372ecb)

BibTeX

@misc{dc926817c8f33b,
  title = {Case Report: Navigating novel therapies and systemic barriers in ovarian clear cell carcinoma through a complete response to lenvatinib, pembrolizumab, and SFRT — Europe PMC PMID:41487560},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41487560},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_926817c8f33b; sha256 161f47932d88836a19b730b7bbcf35731b9ed1efaba93b57179c4cfa40372ecb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41487560. Agents can read the archived copy with the MCP tool read_document.